Analysis and Optimization of Predictive and Therapeutic Models in Uterine Neoplasms

Launched by UNIVERSITY HOSPITAL TUEBINGEN · Aug 6, 2018

Keywords

ClinConnect Summary

This clinical trial is focused on improving treatments for women with uterine neoplasms, which include different types of cancers such as cervical and endometrial cancer. Researchers are studying new experimental results to find better ways to predict outcomes and develop personalized treatment plans for patients. The goal is to create a new algorithm, or step-by-step guide, that helps doctors determine the best therapy for each patient based on their specific condition.

To be eligible for this study, participants need to have a confirmed diagnosis of a uterine cancer and must be 18 years or older. If surgery is an option, they should be able to undergo either laparoscopic (minimally invasive) or open surgery. Participants will need to provide written consent and be willing to follow all study procedures. It's important to note that individuals with severe recent health issues, certain psychiatric disorders, or difficulties understanding the study may not qualify. Those who join can expect to contribute to important research that aims to enhance treatment options for future patients with similar conditions.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Confirmed uterine malignancy ( cervical cancer, endometrial cancer, sarcoma)
• • If operable: surgical primary therapy: laparoscopic/robot-assisted or open radical gyneco-oncological surgery
• • Written consent
• • Willingness and ability to participate in all study-specific procedures
• • Age ≥ 18 years
• Exclusion Criteria:
• • Severe and acute general disease in the last 4 weeks
• • Acute or chronic psychiatric disorders
• • Other factors questioning study participation (e.g. acute psychosocial stress, insufficient understanding of nature and consequences of the study, inadequate skills of the German language)